JP2004530669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004530669A5 JP2004530669A5 JP2002580978A JP2002580978A JP2004530669A5 JP 2004530669 A5 JP2004530669 A5 JP 2004530669A5 JP 2002580978 A JP2002580978 A JP 2002580978A JP 2002580978 A JP2002580978 A JP 2002580978A JP 2004530669 A5 JP2004530669 A5 JP 2004530669A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- composition according
- composition
- cyclooxygenase
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28438101P | 2001-04-17 | 2001-04-17 | |
| US32695201P | 2001-10-04 | 2001-10-04 | |
| PCT/US2002/011689 WO2002083177A1 (en) | 2001-04-17 | 2002-04-12 | Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004530669A JP2004530669A (ja) | 2004-10-07 |
| JP2004530669A5 true JP2004530669A5 (enExample) | 2005-12-22 |
Family
ID=26962574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580978A Withdrawn JP2004530669A (ja) | 2001-04-17 | 2002-04-12 | 微細自己乳化医薬組成物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030105141A1 (enExample) |
| EP (1) | EP1379279A1 (enExample) |
| JP (1) | JP2004530669A (enExample) |
| KR (1) | KR20040018355A (enExample) |
| CN (1) | CN1516601A (enExample) |
| AR (1) | AR033221A1 (enExample) |
| AU (1) | AU2002305175B2 (enExample) |
| BR (1) | BR0208994A (enExample) |
| CA (1) | CA2444220A1 (enExample) |
| CZ (1) | CZ20032792A3 (enExample) |
| EA (1) | EA008103B1 (enExample) |
| IL (1) | IL158201A0 (enExample) |
| MX (1) | MXPA03009411A (enExample) |
| NO (1) | NO20034629L (enExample) |
| NZ (1) | NZ528741A (enExample) |
| PE (1) | PE20021145A1 (enExample) |
| PL (1) | PL364524A1 (enExample) |
| WO (1) | WO2002083177A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| EP1344523A1 (en) * | 2002-03-11 | 2003-09-17 | Warner-Lambert Company | Ibuprofen solution for hard gelatin capsules |
| IL164163A0 (en) * | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| WO2004073492A2 (en) * | 2003-02-14 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
| JP5296314B2 (ja) * | 2003-07-17 | 2013-09-25 | バナー ファーマキャップス，インコーポレイティド | 制御放出製剤 |
| EP1510206A1 (en) * | 2003-08-29 | 2005-03-02 | Novagali Pharma SA | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| SG164378A1 (en) | 2005-02-17 | 2010-09-29 | Synta Pharmaceuticals Corp | Compounds for the treatment of proliferative disorders |
| CN101351196B (zh) | 2005-10-26 | 2013-07-03 | 班纳制药公司 | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 |
| US8333989B2 (en) | 2005-10-26 | 2012-12-18 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| ES2382026T3 (es) * | 2007-09-27 | 2012-06-04 | Wockhardt Limited | Composiciones farmacéuticas autoemulsionantes de reína o diacereína |
| UA102120C2 (ru) * | 2008-12-03 | 2013-06-10 | Астеллас Дойчленд Гмбх | Пероральная форма дозирования бендамустина |
| ES2661812T3 (es) | 2009-10-16 | 2018-04-04 | Mochida Pharmaceutical Co., Ltd. | Composiciones |
| CN103037851A (zh) * | 2010-06-02 | 2013-04-10 | 安斯泰来德国有限公司 | 苯达莫司汀的口服剂型 |
| JO3659B1 (ar) | 2010-06-02 | 2020-08-27 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية |
| EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
| US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
| US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| TW201322979A (zh) * | 2011-10-18 | 2013-06-16 | 拉夸里亞創藥股份有限公司 | 醫藥組成物 |
| CN105007947B (zh) * | 2013-01-14 | 2019-02-15 | 因佛斯特医疗有限公司 | 固溶体组合物及其在心血管疾病中的用途 |
| KR20150129664A (ko) * | 2013-02-04 | 2015-11-20 | 인퍼스트 헬스케어 리미티드 | 만성 염증 및 염증성 질병을 치료하기 위한 조성물 및 방법 |
| CN105491886B (zh) | 2013-08-27 | 2019-01-29 | V·沃道里斯 | 苯达莫司汀医药组合物 |
| CN109477010B (zh) | 2016-07-05 | 2021-07-23 | 戈登可再生能源有限公司 | 用于将废弃塑料转化成燃料的系统和工艺 |
| US12213510B2 (en) | 2019-09-11 | 2025-02-04 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
| CN113750043A (zh) * | 2021-09-18 | 2021-12-07 | 山东省药学科学院 | 一种塞来昔布自乳化口服液及其制备方法 |
| WO2024142089A1 (en) * | 2022-12-27 | 2024-07-04 | Cipla Limited | Injectable compositions of celecoxib |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO118291B1 (ro) * | 1993-11-30 | 2003-04-30 | Searle & Co | Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine |
| US5571536A (en) * | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5733909A (en) * | 1996-02-01 | 1998-03-31 | Merck Frosst Canada, Inc. | Diphenyl stilbenes as prodrugs to COX-2 inhibitors |
| AU750125B2 (en) * | 1997-08-27 | 2002-07-11 | Hexal Ag | New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| MY120279A (en) * | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
| AU2001282886A1 (en) * | 2000-07-13 | 2002-01-30 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
-
2002
- 2002-04-09 US US10/119,129 patent/US20030105141A1/en not_active Abandoned
- 2002-04-12 EP EP02733979A patent/EP1379279A1/en not_active Withdrawn
- 2002-04-12 EA EA200301019A patent/EA008103B1/ru not_active IP Right Cessation
- 2002-04-12 JP JP2002580978A patent/JP2004530669A/ja not_active Withdrawn
- 2002-04-12 WO PCT/US2002/011689 patent/WO2002083177A1/en not_active Ceased
- 2002-04-12 PL PL02364524A patent/PL364524A1/xx not_active Application Discontinuation
- 2002-04-12 AU AU2002305175A patent/AU2002305175B2/en not_active Ceased
- 2002-04-12 BR BR0208994-7A patent/BR0208994A/pt not_active IP Right Cessation
- 2002-04-12 NZ NZ528741A patent/NZ528741A/en unknown
- 2002-04-12 CA CA002444220A patent/CA2444220A1/en not_active Abandoned
- 2002-04-12 KR KR10-2003-7013651A patent/KR20040018355A/ko not_active Ceased
- 2002-04-12 IL IL15820102A patent/IL158201A0/xx unknown
- 2002-04-12 CN CNA028120787A patent/CN1516601A/zh active Pending
- 2002-04-12 CZ CZ20032792A patent/CZ20032792A3/cs unknown
- 2002-04-12 MX MXPA03009411A patent/MXPA03009411A/es not_active Application Discontinuation
- 2002-04-16 PE PE2002000315A patent/PE20021145A1/es not_active Application Discontinuation
- 2002-04-17 AR ARP020101396A patent/AR033221A1/es unknown
-
2003
- 2003-10-16 NO NO20034629A patent/NO20034629L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505660A5 (enExample) | ||
| JP2009541223A5 (enExample) | ||
| JP2019500387A5 (enExample) | ||
| RU2009138500A (ru) | 4, -о-замещенные изоиндолиновые производные и содержащие их композиции и способы их применения | |
| JP2009524675A5 (enExample) | ||
| RU2004130291A (ru) | Способ получения самостоятельно мелко эмульгирующейся фармацевтичес кой композиции | |
| JP2005500363A5 (enExample) | ||
| JP2015535247A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2014530900A5 (enExample) | ||
| JP6261011B2 (ja) | 眼疾患処置薬 | |
| JP2020524178A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| RU2009136592A (ru) | Терапевтические агенты | |
| JP2020505354A5 (enExample) | ||
| JP2015510930A5 (enExample) | ||
| JP2011507879A5 (enExample) | ||
| JP2008538784A (ja) | 膀胱機能を調節するための方法 | |
| JP2013522368A5 (enExample) | ||
| JP2024095711A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| JP2012510985A5 (enExample) | ||
| JP2017515899A5 (enExample) | ||
| JP2019516709A5 (enExample) | ||
| US20120213867A1 (en) | Raf inhibitors for the treatment of thyroid cancer | |
| JP2019516726A5 (enExample) |